Inpatient Glucose Management: Part 1
Risks and Complications
Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations and would prefer little or no occurrence. The detrimental obstacles include:
- Hyperglycemia – High blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality and escalated cost.
- Hypoglycemia – Low blood sugar in hospitalized patients is the most common acute adverse effect of glucose-lowering therapy among patients with diabetes mellitus. Hypoglycemia is also associated with poor outcomes.
- Poor treatment and/or lack of control – Poor glucose management is directly linked to higher hyperglycemia and hypoglycemia rates, and poor manifestation of glucose control leads to lower reimbursements, poor outcomes and mortality.
- Hospital-acquired conditions – Manifestations of poor glycemic control include diabetic ketoacidosis (DKA), nonketotic hyperosmolar coma, hypoglycemic coma, secondary diabetes with ketoacidosis, and secondary diabetes with hyperosmolarity.
In our upcoming blogs, we will discuss the American Diabetes Association and Joint Commission guidelines on best practices for overcoming these risks and complications.
Related posts

Blog
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
As a Customer Success Manager of EndoTool, I've had the privilege of working with healthcare systems that are deeply committed to improving patient outcomes. Temple Health is one of those organizations. Their system-wide rollout of EndoTool SubQ wasn't just an ...

News
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions. For EndoTool customers, nothing changes in the care and support you receive. ...

Blog
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
When clinicians ask me, "How do we move beyond standard insulin protocols and implement a glycemic management software solution without getting stuck in committee?" My answer is simple: pair clinical impact with financial clarity. Below are five practical tips I've ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields